Chitosan Market By Source (Shrimp, Squid, Crab, Krill, Others) , By Application (Water treatment, Biomedical and Pharmaceutical, Cosmetics, Food and Beverage, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The chitosan market was valued at $7.8 billion in 2023, and is projected t%li%reach $42.8 billion by 2033, growing at a CAGR of 18.7% from 2024 t%li%2033.
Chitosan is a natural biopolymer that is synthesized in the outer skeleton of shellfish such as lobster, shrimp, and crab. This biopolymer is derived from chitin through a process of deacetylation, which converts it int%li%chitosan. It exhibits a myriad of properties such as biocompatibility, biodegradability, antimicrobial activity, and antioxidant properties, which make suitable for use in a wide range of applications; for instance, it used in dietary supplements, food packaging, and in wound care.
The growth of the global chitosan market is majorly driven by surge in demand for chitosan from various industries, including healthcare, pharmaceuticals, food & beverages, and agriculture. Chitosan is non-toxic and compatible with human tissues, making it suitable for medical and pharmaceutical applications, including wound dressings, drug delivery systems, and tissue engineering. Its antimicrobial, biocompatible, and water retention properties aid in wound healing and skin care. For instance, according t%li%the 2018 estimates of the European Centre for Disease Prevention and Control (ECDC), nearly 33,000 individuals die every year due t%li%infection with antibiotic-resistant bacteria. This has necessitated the development of developing new antimicrobials from natural and synthetic molecules, which, in turn, has fostered the demand for chitosan in the medical sector. In addition, chitosan's exhibits the ability t%li%bind with contaminants, including heavy metals and dyes, which makes it a sustainable choice for water treatment. In addition, as the world’s food demand is aligning with the increasing global population, the need for sustainable agricultural practices has increased notably. Chitosan serves as a sustainable alternative t%li%conventional agrochemicals, thus fostering the adoption of safer agricultural practices. This is attributed t%li%the fact that chitosan-based formulations can effectively control pests and diseases, reduce the need for chemical pesticides, and improve crop yields, which boosts its demand in the agricultural sector.
Some studies claim that chitosan assists in weight loss and lowers cholesterol levels by eliminating fat and cholesterol from the body instead of allowing the body t%li%absorb them. However, current studies d%li%not support this claim. Clinical trials conducted in the early 2000s found that chitosan did not facilitate fat excretion in stool, and there is n%li%indication that it traps fat. Thus, such discrepancies hamper the demand for chitosan supplements, which significantly hampers the growth of the global market. High production costs of chitosan further acts as a key deterrent factor of the global market. Contrarily, surge in demand for chitosan as a natural preservative t%li%extend the shelf life of food products due t%li%its antimicrobial properties. Thus, manufacturers are focusing on the development of edible chitosan-based edible films and coatings t%li%prevent the spoilage of food products, which is expected t%li%offer remunerative opportunities for the growth of the market during the forecast period.
The chitosan market is segmented int%li%source, application, and region. By source, the market is classified int%li%shrimp, squid, crab, krill, and others. On the basis of application, it is divided int%li%water treatment, biomedical & pharmaceutical, cosmetics, food & beverage, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By source, the shrimp segment held the highest market share in 2023 and is likely t%li%retain its dominance by 2033.
Depending on application, the water treatment segment was the major shareholder in 2023 and is expected t%li%continue the same trend during the forecast period.
Region wise, Asia-Pacific is expected t%li%experience the fastest growth during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global chitosan market include PRIMEX EHF, ADVANCED BIOPOLYMERS AS, Panv%li%Organics Pvt Ltd., Heppe Medical Chitosan GmbH, G.T.C. Bi%li%Corporation, Kitozyme S.A., Novamatrix, Agratech International, Inc., Golden-Shell Pharmaceutical Co. Ltd., and Qingda%li%Yunzhou Biochemistry Co. Ltd. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
By Source
Chitosan is a natural biopolymer that is synthesized in the outer skeleton of shellfish such as lobster, shrimp, and crab. This biopolymer is derived from chitin through a process of deacetylation, which converts it int%li%chitosan. It exhibits a myriad of properties such as biocompatibility, biodegradability, antimicrobial activity, and antioxidant properties, which make suitable for use in a wide range of applications; for instance, it used in dietary supplements, food packaging, and in wound care.
The growth of the global chitosan market is majorly driven by surge in demand for chitosan from various industries, including healthcare, pharmaceuticals, food & beverages, and agriculture. Chitosan is non-toxic and compatible with human tissues, making it suitable for medical and pharmaceutical applications, including wound dressings, drug delivery systems, and tissue engineering. Its antimicrobial, biocompatible, and water retention properties aid in wound healing and skin care. For instance, according t%li%the 2018 estimates of the European Centre for Disease Prevention and Control (ECDC), nearly 33,000 individuals die every year due t%li%infection with antibiotic-resistant bacteria. This has necessitated the development of developing new antimicrobials from natural and synthetic molecules, which, in turn, has fostered the demand for chitosan in the medical sector. In addition, chitosan's exhibits the ability t%li%bind with contaminants, including heavy metals and dyes, which makes it a sustainable choice for water treatment. In addition, as the world’s food demand is aligning with the increasing global population, the need for sustainable agricultural practices has increased notably. Chitosan serves as a sustainable alternative t%li%conventional agrochemicals, thus fostering the adoption of safer agricultural practices. This is attributed t%li%the fact that chitosan-based formulations can effectively control pests and diseases, reduce the need for chemical pesticides, and improve crop yields, which boosts its demand in the agricultural sector.
Some studies claim that chitosan assists in weight loss and lowers cholesterol levels by eliminating fat and cholesterol from the body instead of allowing the body t%li%absorb them. However, current studies d%li%not support this claim. Clinical trials conducted in the early 2000s found that chitosan did not facilitate fat excretion in stool, and there is n%li%indication that it traps fat. Thus, such discrepancies hamper the demand for chitosan supplements, which significantly hampers the growth of the global market. High production costs of chitosan further acts as a key deterrent factor of the global market. Contrarily, surge in demand for chitosan as a natural preservative t%li%extend the shelf life of food products due t%li%its antimicrobial properties. Thus, manufacturers are focusing on the development of edible chitosan-based edible films and coatings t%li%prevent the spoilage of food products, which is expected t%li%offer remunerative opportunities for the growth of the market during the forecast period.
The chitosan market is segmented int%li%source, application, and region. By source, the market is classified int%li%shrimp, squid, crab, krill, and others. On the basis of application, it is divided int%li%water treatment, biomedical & pharmaceutical, cosmetics, food & beverage, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By source, the shrimp segment held the highest market share in 2023 and is likely t%li%retain its dominance by 2033.
Depending on application, the water treatment segment was the major shareholder in 2023 and is expected t%li%continue the same trend during the forecast period.
Region wise, Asia-Pacific is expected t%li%experience the fastest growth during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global chitosan market include PRIMEX EHF, ADVANCED BIOPOLYMERS AS, Panv%li%Organics Pvt Ltd., Heppe Medical Chitosan GmbH, G.T.C. Bi%li%Corporation, Kitozyme S.A., Novamatrix, Agratech International, Inc., Golden-Shell Pharmaceutical Co. Ltd., and Qingda%li%Yunzhou Biochemistry Co. Ltd. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Analysis of raw material in a product (by %)
- Manufacturing Capacity
- Product Benchmarking / Product specification and applications
- Product Life Cycles
- Supply Chain Analysis & Vendor Margins
- Upcoming/New Entrant by Regions
- Average Consumer Expenditure
- G%li%T%li%Market Strategy
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Pain Point Analysis
- Regulatory Guidelines
- Strategic Recommendations
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Average Selling Price Analysis / Price Point Analysis
- Expanded list for Company Profiles
- Historic market data
- Import Export Analysis/Data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- List of customers/consumers/raw material suppliers- value chain analysis
- Market share analysis of players at global/region/country level
- Per Capita Consumption Trends
- SWOT Analysis
- Volume Market Size and Forecast
By Source
- Shrimp
- Squid
- Crab
- Krill
- Others
- Water treatment
- Biomedical and Pharmaceutical
- Cosmetics
- Food and Beverage
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- PRIMEX EHF
- ADVANCED BIOPOLYMERS AS
- Panv%li%Organics Pvt Ltd.
- Heppe Medical Chitosan GmbH
- G.T.C. Bi%li%Corporation
- Kitozyme S.A.
- Novamatrix
- Agratech International, Inc.
- Golden-Shell Pharmaceutical Co. Ltd.
- Qingda%li%Yunzhou Biochemistry Co. Ltd.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Reagents
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Instruments
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Software And Services
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Enzyme-linked Immunosorbent Assay
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Chemiluminescence Immunoassay
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Fluorescent Immunoassay
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Radioimmunoassay
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: IMMUNODIAGNOSTICS MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Infectious Diseases
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Oncology Endocrinology
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Bone Mineral Diseases
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Autoimmunity Disorders
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Cardiac Biomarkers
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Drug Monitoring
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Others
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
CHAPTER 7: IMMUNODIAGNOSTICS MARKET, BY END-USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End-user
7.2. Hospitals
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Clinical Laboratories
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Academic Research Institutes
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
7.5. Others
7.5.1. Key Market Trends, Growth Factors and Opportunities
7.5.2. Market Size and Forecast, By Region
7.5.3. Market Share Analysis, By Country
CHAPTER 8: IMMUNODIAGNOSTICS MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product Type
8.2.3. Market Size and Forecast, By Technology
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End-user
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Immunodiagnostics Market
8.2.7.1. Market Size and Forecast, By Product Type
8.2.7.2. Market Size and Forecast, By Technology
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End-user
8.2.8. Canada Immunodiagnostics Market
8.2.8.1. Market Size and Forecast, By Product Type
8.2.8.2. Market Size and Forecast, By Technology
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End-user
8.2.9. Mexico Immunodiagnostics Market
8.2.9.1. Market Size and Forecast, By Product Type
8.2.9.2. Market Size and Forecast, By Technology
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End-user
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product Type
8.3.3. Market Size and Forecast, By Technology
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End-user
8.3.6. Market Size and Forecast, By Country
8.3.7. France Immunodiagnostics Market
8.3.7.1. Market Size and Forecast, By Product Type
8.3.7.2. Market Size and Forecast, By Technology
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End-user
8.3.8. Germany Immunodiagnostics Market
8.3.8.1. Market Size and Forecast, By Product Type
8.3.8.2. Market Size and Forecast, By Technology
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End-user
8.3.9. Italy Immunodiagnostics Market
8.3.9.1. Market Size and Forecast, By Product Type
8.3.9.2. Market Size and Forecast, By Technology
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End-user
8.3.10. Spain Immunodiagnostics Market
8.3.10.1. Market Size and Forecast, By Product Type
8.3.10.2. Market Size and Forecast, By Technology
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End-user
8.3.11. UK Immunodiagnostics Market
8.3.11.1. Market Size and Forecast, By Product Type
8.3.11.2. Market Size and Forecast, By Technology
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End-user
8.3.12. Rest of Europe Immunodiagnostics Market
8.3.12.1. Market Size and Forecast, By Product Type
8.3.12.2. Market Size and Forecast, By Technology
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End-user
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product Type
8.4.3. Market Size and Forecast, By Technology
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End-user
8.4.6. Market Size and Forecast, By Country
8.4.7. China Immunodiagnostics Market
8.4.7.1. Market Size and Forecast, By Product Type
8.4.7.2. Market Size and Forecast, By Technology
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End-user
8.4.8. Japan Immunodiagnostics Market
8.4.8.1. Market Size and Forecast, By Product Type
8.4.8.2. Market Size and Forecast, By Technology
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End-user
8.4.9. India Immunodiagnostics Market
8.4.9.1. Market Size and Forecast, By Product Type
8.4.9.2. Market Size and Forecast, By Technology
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End-user
8.4.10. South Korea Immunodiagnostics Market
8.4.10.1. Market Size and Forecast, By Product Type
8.4.10.2. Market Size and Forecast, By Technology
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End-user
8.4.11. Australia Immunodiagnostics Market
8.4.11.1. Market Size and Forecast, By Product Type
8.4.11.2. Market Size and Forecast, By Technology
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End-user
8.4.12. Rest of Asia-Pacific Immunodiagnostics Market
8.4.12.1. Market Size and Forecast, By Product Type
8.4.12.2. Market Size and Forecast, By Technology
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End-user
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product Type
8.5.3. Market Size and Forecast, By Technology
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End-user
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Immunodiagnostics Market
8.5.7.1. Market Size and Forecast, By Product Type
8.5.7.2. Market Size and Forecast, By Technology
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End-user
8.5.8. South Africa Immunodiagnostics Market
8.5.8.1. Market Size and Forecast, By Product Type
8.5.8.2. Market Size and Forecast, By Technology
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End-user
8.5.9. Saudi Arabia Immunodiagnostics Market
8.5.9.1. Market Size and Forecast, By Product Type
8.5.9.2. Market Size and Forecast, By Technology
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End-user
8.5.10. Rest of LAMEA Immunodiagnostics Market
8.5.10.1. Market Size and Forecast, By Product Type
8.5.10.2. Market Size and Forecast, By Technology
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End-user
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. Abbott
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. Becton Dickinson
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Agilent Technologies, Inc.
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Exact Sciences Corporation
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Guardant Health
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Illumina, Inc.
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. Diaosorin
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. NeoGenomics Laboratories
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. F. Hoffmann-La Roche Ltd.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. Thermo Fisher Scientific Inc.
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Reagents
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Instruments
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Software And Services
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Enzyme-linked Immunosorbent Assay
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Chemiluminescence Immunoassay
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Fluorescent Immunoassay
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Radioimmunoassay
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: IMMUNODIAGNOSTICS MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Infectious Diseases
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Oncology Endocrinology
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Bone Mineral Diseases
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Autoimmunity Disorders
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Cardiac Biomarkers
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Drug Monitoring
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Others
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
CHAPTER 7: IMMUNODIAGNOSTICS MARKET, BY END-USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End-user
7.2. Hospitals
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Clinical Laboratories
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Academic Research Institutes
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
7.5. Others
7.5.1. Key Market Trends, Growth Factors and Opportunities
7.5.2. Market Size and Forecast, By Region
7.5.3. Market Share Analysis, By Country
CHAPTER 8: IMMUNODIAGNOSTICS MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product Type
8.2.3. Market Size and Forecast, By Technology
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End-user
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Immunodiagnostics Market
8.2.7.1. Market Size and Forecast, By Product Type
8.2.7.2. Market Size and Forecast, By Technology
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End-user
8.2.8. Canada Immunodiagnostics Market
8.2.8.1. Market Size and Forecast, By Product Type
8.2.8.2. Market Size and Forecast, By Technology
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End-user
8.2.9. Mexico Immunodiagnostics Market
8.2.9.1. Market Size and Forecast, By Product Type
8.2.9.2. Market Size and Forecast, By Technology
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End-user
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product Type
8.3.3. Market Size and Forecast, By Technology
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End-user
8.3.6. Market Size and Forecast, By Country
8.3.7. France Immunodiagnostics Market
8.3.7.1. Market Size and Forecast, By Product Type
8.3.7.2. Market Size and Forecast, By Technology
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End-user
8.3.8. Germany Immunodiagnostics Market
8.3.8.1. Market Size and Forecast, By Product Type
8.3.8.2. Market Size and Forecast, By Technology
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End-user
8.3.9. Italy Immunodiagnostics Market
8.3.9.1. Market Size and Forecast, By Product Type
8.3.9.2. Market Size and Forecast, By Technology
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End-user
8.3.10. Spain Immunodiagnostics Market
8.3.10.1. Market Size and Forecast, By Product Type
8.3.10.2. Market Size and Forecast, By Technology
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End-user
8.3.11. UK Immunodiagnostics Market
8.3.11.1. Market Size and Forecast, By Product Type
8.3.11.2. Market Size and Forecast, By Technology
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End-user
8.3.12. Rest of Europe Immunodiagnostics Market
8.3.12.1. Market Size and Forecast, By Product Type
8.3.12.2. Market Size and Forecast, By Technology
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End-user
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product Type
8.4.3. Market Size and Forecast, By Technology
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End-user
8.4.6. Market Size and Forecast, By Country
8.4.7. China Immunodiagnostics Market
8.4.7.1. Market Size and Forecast, By Product Type
8.4.7.2. Market Size and Forecast, By Technology
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End-user
8.4.8. Japan Immunodiagnostics Market
8.4.8.1. Market Size and Forecast, By Product Type
8.4.8.2. Market Size and Forecast, By Technology
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End-user
8.4.9. India Immunodiagnostics Market
8.4.9.1. Market Size and Forecast, By Product Type
8.4.9.2. Market Size and Forecast, By Technology
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End-user
8.4.10. South Korea Immunodiagnostics Market
8.4.10.1. Market Size and Forecast, By Product Type
8.4.10.2. Market Size and Forecast, By Technology
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End-user
8.4.11. Australia Immunodiagnostics Market
8.4.11.1. Market Size and Forecast, By Product Type
8.4.11.2. Market Size and Forecast, By Technology
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End-user
8.4.12. Rest of Asia-Pacific Immunodiagnostics Market
8.4.12.1. Market Size and Forecast, By Product Type
8.4.12.2. Market Size and Forecast, By Technology
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End-user
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product Type
8.5.3. Market Size and Forecast, By Technology
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End-user
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Immunodiagnostics Market
8.5.7.1. Market Size and Forecast, By Product Type
8.5.7.2. Market Size and Forecast, By Technology
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End-user
8.5.8. South Africa Immunodiagnostics Market
8.5.8.1. Market Size and Forecast, By Product Type
8.5.8.2. Market Size and Forecast, By Technology
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End-user
8.5.9. Saudi Arabia Immunodiagnostics Market
8.5.9.1. Market Size and Forecast, By Product Type
8.5.9.2. Market Size and Forecast, By Technology
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End-user
8.5.10. Rest of LAMEA Immunodiagnostics Market
8.5.10.1. Market Size and Forecast, By Product Type
8.5.10.2. Market Size and Forecast, By Technology
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End-user
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. Abbott
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. Becton Dickinson
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Agilent Technologies, Inc.
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Exact Sciences Corporation
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Guardant Health
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Illumina, Inc.
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. Diaosorin
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. NeoGenomics Laboratories
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. F. Hoffmann-La Roche Ltd.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. Thermo Fisher Scientific Inc.
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
